Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
U.S. FDA Approves Subcutaneous Administration of Takeda's Entyvio (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Ulcerative Colitis
OSAKA, Japan and CAMBRIDGE, Massachusetts, September 27, 2023 – Takeda today announced that the U.S. Food and Drug Administration (FDA) has approved...
FDA Approves Bosutinib for Pediatric Patients with Chronic Myelogenous Leukemia
On September 26, 2023, the Food and Drug Administration approved bosutinib (Bosulif, Pfizer) for pediatric patients 1 year of age and older with chronic...
FDA Approves Ryzumvi (phentolamine) Ophthalmic Solution for the Treatment of Pharmacologically-Induced Mydriasis
FARMINGTON HILLS, Mich., and PITTSBURGH, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical...
FDA Approves Likmez (metronidazole) Oral Suspension for the Treatment of Parasitic and Anaerobic Bacterial Infections
(BUSINESS WIRE) September 25, 2023 -- Appili Therapeutics Inc. (TSX:APLI; OTCQB: APLIF) (the “Company” or “Appili”), a biopharmaceutical...
CDC: 22 States Have an Adult Obesity Prevalence ≥35 Percent
Twenty-two states have an adult obesity prevalence at or above 35 percent, up from 2021, according to data recently released by the U.S. Centers for Disease...
Bariatric Surgery Linked to Reduced Incidence of Hematologic Cancer
Bariatric surgery is associated with reduced incidence of hematological cancer, especially for women, according to a study published online Sept. 13 in...
Less than One Quarter 'Definitely' Plan to Get New COVID-19 Vaccine
Just 23 percent of American adults say they "definitely" will get the new COVID-19 vaccine, while another 23 percent say they will "probably" get it, according...
Risk of Ileus Added to Ozempic Label
Ozempic will now be labeled as having the potential to block intestines. The U.S. Food and Drug Administration recently made the label update for the drug...
FDA Adds Warning to Ozempic Label About Risk for Blocked Intestines
Ozempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines. The...
Fast-Acting Investigational Nasal Spray May Ease Rapid Heartbeat
Up to 2 million people in the U.S. experience rapid-fire heartbeats from time to time, and many end up in the hospital for treatment. But an investigational...
Stem Cell Treatment Halts MS for Some Patients
A new study is strengthening the evidence that stem cell transplants can be highly effective for some people with multiple sclerosis -- sending the disease...
Emotional Issues Could Be Early Sign of MS
A newer understanding of multiple sclerosis (MS) suggests that psychiatric conditions like anxiety and depression may emerge long before classic MS symptoms. “For...
NMD Pharma initiates Phase II trial of NMD670 in Spinal Muscular Atrophy
Aarhus, Denmark, 26 September 2023 – NMD Pharma A/S, a clinical-stage biotech company developing first-in-class, small molecule ClC-1 inhibitors...
Reviva Announces Last Patient Evaluated in Pivotal Phase 3 RECOVER Trial for Brilaroxazine in Schizophrenia
CUPERTINO, Calif., Sept. 25, 2023. Reviva Pharmaceuticals Holdings, Inc. (“Reviva” or the “Company”), a late-stage pharmaceutical...
Your Wrist Could Give Clues to Future Health
One day, it may be possible to monitor people for risk of disease through continuously measuring skin temperature. Researchers have found in a new study...
FDA Accepts Submission to Add PH-ILD to Yutrepia™ Label
Liquidia Corporation (the Company) (NASDAQ: LQDA) announced today that the U.S. Food and Drug Administration (FDA) accepted for review the Company’s...
VistaPharm LLC Issues Voluntary Nationwide Recall of Sucralfate Oral Suspension, 1g/10mL Due to Microbial Contamination Identified as Bacillus Cereus
September 22, 2023 – Largo, Florida, VistaPharm LLC is voluntarily recalling one (1) lot of Sucralfate Oral Suspension, 1g/10mL, to the consumer...
Recently Added
Recently added consumer and prescribing information: Likmez, Ojjaara, Tyruko, Bylvay, Xdemvy, Cyfendus, Ycanth, Beyfortus, Roctavian, Lantidra
For Consumers
- Cerner Multum Drug Information
- IBM Watson Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- IBM Watson Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Ryzumvi Ryzumvi (phentolamine mesylate) is a nonselective alpha adrenergic antagonist ophthalmic formulation in development for the reversal of...
- Likmez Likmez (metronidazole) is an oral liquid suspension formulation of the approved antibiotic metronidazole for the treatment of parasitic and...
- Ojjaara Ojjaara (momelotinib) is a JAK1/JAK2 and activin A receptor type 1 (ACVR1) inhibitor for the treatment of myelofibrosis patients with anemia.
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...
- Libervant Libervant (diazepam) is a buccal film formulation of the approved benzodiazepine diazepam in development for the management of seizure clusters.